Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Daenen

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|August 27, 1988
[Malignant histiocytosis, true histiocytic lymphoma, acute monoblastic leukemia; forms of degeneration in the monocytoid series]M Bins, S M Daenen
JAMA Oncology|September 11, 2015
Let Them Eat Fish--ReplyLaura G M Daenen, Emile E Voest
The European Respiratory Journal|May 28, 2002
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?W Willaert, M Daenen, P Bomans, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 31, 2003
Hyperresponsiveness to phencyclidine in animals lesioned in the amygdala on day 7 of life. Implications for an animal model of schizophreniaE W P M Daenen, G Wolterink, J M Van Ree
Current Clinical Pharmacology|April 22, 2010
Vascular disrupting agents (VDAs) in anticancer therapyLaura G M Daenen, Jeanine M L Roodhart, Yuval Shaked, et al.
Archives of Internal Medicine|July 25, 2000
Successful treatment of massive hemoptysis in acute leukemia with recombinant factor VIIaK Meijer, W E de Graaff, S M Daenen, et al.
Mutation Research|August 1, 1986
Contribution of wood stoves and fire places to mutagenic activity of airborne particulate matter inside homesJ J van Houdt, C M Daenen, J S Boleij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
Hemolytic-uremic syndrome caused by gemcitabineK Nackaerts, M Daenen, J Vansteenkiste, et al.
The European Respiratory Journal|June 3, 2000
Occupational asthma caused by palladiumM Daenen, P Rogiers, C Van de Walle, et al.
British Journal of Cancer|May 19, 2012
The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progressionJ M Houthuijzen, L G M Daenen, J M L Roodhart, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Nederlands Tijdschrift Voor Geneeskunde|August 27, 1988
[Malignant histiocytosis, true histiocytic lymphoma, acute monoblastic leukemia; forms of degeneration in the monocytoid series]M Bins, S M Daenen
JAMA Oncology|September 11, 2015
Let Them Eat Fish--ReplyLaura G M Daenen, Emile E Voest
The European Respiratory Journal|May 28, 2002
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?W Willaert, M Daenen, P Bomans, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 31, 2003
Hyperresponsiveness to phencyclidine in animals lesioned in the amygdala on day 7 of life. Implications for an animal model of schizophreniaE W P M Daenen, G Wolterink, J M Van Ree
Current Clinical Pharmacology|April 22, 2010
Vascular disrupting agents (VDAs) in anticancer therapyLaura G M Daenen, Jeanine M L Roodhart, Yuval Shaked, et al.
Archives of Internal Medicine|July 25, 2000
Successful treatment of massive hemoptysis in acute leukemia with recombinant factor VIIaK Meijer, W E de Graaff, S M Daenen, et al.
Mutation Research|August 1, 1986
Contribution of wood stoves and fire places to mutagenic activity of airborne particulate matter inside homesJ J van Houdt, C M Daenen, J S Boleij, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
Hemolytic-uremic syndrome caused by gemcitabineK Nackaerts, M Daenen, J Vansteenkiste, et al.
The European Respiratory Journal|June 3, 2000
Occupational asthma caused by palladiumM Daenen, P Rogiers, C Van de Walle, et al.
British Journal of Cancer|May 19, 2012
The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progressionJ M Houthuijzen, L G M Daenen, J M L Roodhart, et al.
Pageof 6